Betta Pharmaceuticals Co., Ltd. (SHE:300558)

Betta Pharmaceuticals Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Market Capitalization	20,648	22,569	21,573	20,525	33,154	44,361
Market Cap Growth	25.20%	4.62%	5.11%	-38.09%	-25.26%	68.38%
Enterprise Value	22,526	24,170	23,045	20,899	31,905	43,858
Last Close Price	49.34	53.93	51.32	48.98	78.91	105.81
PE Ratio	50.85	56.06	61.99	141.14	86.55	73.16
Forward PE	26.01	29.63	42.25	65.91	49.20	99.01
PS Ratio	6.72	7.80	8.78	8.64	14.76	23.72
PB Ratio	3.67	3.98	4.03	4.14	7.08	10.70
P/TBV Ratio	8.45	9.47	7.45	6.38	11.18	14.20
P/FCF Ratio	81.04	270.04	-	-	-	-
P/OCF Ratio	21.48	24.77	23.60	66.91	62.96	68.67
PEG Ratio	-	3.08	3.08	3.08	3.08	3.08
EV/Sales Ratio	7.33	8.36	9.38	8.79	14.21	23.45
EV/EBITDA Ratio	23.64	28.60	39.86	46.08	61.61	76.95
EV/EBIT Ratio	39.98	50.68	82.34	100.98	91.48	105.74
EV/FCF Ratio	88.41	289.20	-	-	-	-
Debt / Equity Ratio	0.42	0.42	0.45	0.21	0.00	0.00
Debt / EBITDA Ratio	2.50	2.82	4.17	2.27	0.02	0.00
Debt / FCF Ratio	9.37	28.67	-	-	-	-
Asset Turnover	0.33	0.31	0.29	0.34	0.39	0.40
Inventory Turnover	1.82	1.74	1.16	0.81	0.72	0.86
Quick Ratio	0.36	0.38	0.58	0.59	1.36	3.64
Current Ratio	0.62	0.66	0.85	0.82	1.86	4.22
Return on Equity (ROE)	6.91%	7.03%	6.47%	2.59%	8.60%	18.18%
Return on Assets (ROA)	3.82%	3.23%	2.05%	1.82%	3.79%	5.54%
Return on Capital (ROIC)	4.38%	3.76%	2.54%	2.42%	4.93%	7.14%
Return on Capital Employed (ROCE)	8.00%	6.40%	3.80%	3.60%	6.50%	8.70%
Earnings Yield	1.96%	1.78%	1.61%	0.71%	1.16%	1.37%
FCF Yield	1.23%	0.37%	-0.84%	-3.43%	-0.70%	-0.09%
Dividend Yield	0.41%	0.37%	0.33%	0.14%	0.32%	0.29%
Payout Ratio	39.35%	37.48%	31.69%	95.94%	35.93%	19.74%
Buyback Yield / Dilution	0.47%	-0.01%	-0.72%	0.02%	-2.32%	-1.09%
Total Shareholder Return	0.88%	0.36%	-0.39%	0.16%	-2.00%	-0.80%

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.